BNTX BioNTech SE Stock Quote

Your browser is no longer supported. Please, upgrade your browser.

publish chart | save to portfolio | create alert

Settings

BNTX [NASD]

BioNTech SE

Healthcare | Biotechnology | Germany

statements

Index	-	P/E	-	EPS (ttm)	-0.57	Insider Own	1.26%	Shs Outstand	231.75M	Perf Week	1.23%
Market Cap	15.66B	Forward P/E	-	EPS next Y	-0.56	Insider Trans	0.00%	Shs Float	217.29M	Perf Month	38.50%
Income	-130.00M	PEG	-	EPS next Q	-0.23	Inst Own	3.30%	Short Float	1.41%	Perf Quarter	48.16%
Sales	153.10M	P/S	102.27	EPS this Y	-300.50%	Inst Trans	-21.56%	Short Ratio	1.67	Perf Half Y	55.88%
Book/sh	-	P/B	-	EPS next Y	42.40%	ROA	-	Target Price	41.46	Perf Year	-
Cash/sh	2.31	P/C	29.27	EPS next 5Y	-	ROE	-	52W Range	12.52 - 105.00	Perf YTD	99.41%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-31.40%	52W High	-35.66%	Beta	-
Dividend %	-	Quick Ratio	3.70	Sales past 5Y	-	Gross Margin	88.30%	52W Low	439.40%	ATR	4.96
Employees	1179	Current Ratio	3.70	Sales Q/Q	5.80%	Oper. Margin	-	RSI (14)	66.85	Volatility	11.37% 8.01%
Optionable	Yes	Debt/Eq	0.21	EPS Q/Q	-	Profit Margin	-	Rel Volume	0.79	Prev Close	67.56
Shortable	Yes	LT Debt/Eq	0.16	Earnings	May 12 BMO	Payout	-	Avg Volume	1.83M	Price	67.56
Recom	2.60	SMA20	17.74%	SMA50	28.12%	SMA200	76.29%	Volume	0	Change	0.00%

Jun-30-20

Downgrade

H.C. Wainwright

Buy → Neutral

May-19-20

Upgrade

H.C. Wainwright

Neutral → Buy

$48 → $69

Apr-28-20

Downgrade

BofA/Merrill

Buy → Neutral

$46 → $51

Mar-18-20

Downgrade

JP Morgan

Overweight → Neutral

$23 → $33

Mar-09-20

Initiated

H.C. Wainwright

Neutral

$30

Jan-24-20

Downgrade

SVB Leerink

Outperform → Mkt Perform

Jan-22-20

Downgrade

UBS

Buy → Neutral

$35

Nov-05-19

Initiated

Wolfe Research

Outperform

Nov-04-19

Initiated

UBS

Buy

$21

Nov-04-19

Initiated

SVB Leerink

Outperform

Nov-04-19

Initiated

JP Morgan

Overweight

$23

Nov-04-19

Initiated

Canaccord Genuity

Buy

$22

Nov-04-19

Initiated

BofA/Merrill

Buy

$21

Nov-04-19

Initiated

Berenberg

Buy

$25

Jul-08-20 10:05AM	Here's Why BioNTech Gained 34.8% in June Motley Fool
Jul-07-20 06:45AM	Does Pfizer's COVID-19 Vaccine Make the Big Pharma Stock a Buy? Motley Fool +5.85%
Jul-04-20 09:25AM	After months of speculation, investors get excited about Pfizer, BioNTechs coronavirus vaccine candidate MarketWatch
Jul-02-20 12:34PM	European stocks surge as U.S. economy adds 4.8 million jobs in June MarketWatch
11:05AM	Pfizer Reports Encouarging Data From Coronavirus Program Zacks
09:32AM	What could save the stock market in July? More government borrowing and Federal Reserve money printing MarketWatch
09:09AM	Pfizer Stock Rises as Company Unveils Aggressive Timeline for Coronavirus Vaccine Barrons.com
08:42AM	Implied Volatility Surging for BioNTech (BNTX) Stock Options Zacks
06:21AM	Coronavirus update: U.S. case tally climbs above 2.6 million, and top Republicans now call on Americans to wear face masks MarketWatch
Jul-01-20 11:41PM	Asian markets rise on vaccine hopes, signs of improving global economy MarketWatch
08:13PM	Gold Down Over Hopes For a COVID-19 Vaccine Investing.com
06:07PM	Why Pfizer Stock Rose Today Motley Fool
03:18PM	Coronavirus latest: Wednesday, July 1 Yahoo Finance Video
02:36PM	Pfizer and BioNTech Post Positive Trial Data for Their COVID-19 Vaccine Motley Fool
01:21PM	Pfizer, BioNTech Report Promising Initial Data From Coronavirus Vaccine Study Benzinga
11:54AM	Why Moderna Shares Are Sliding Today Motley Fool
11:06AM	Dow Turns Losses Into Gains After Pfizer Releases Vaccine Data Barrons.com
10:52AM	Virus Shot From Pfizer, BioNtech Shows Promise in Early Test Bloomberg
10:21AM	Pfizer Offers Hope, and Details, on Potential Coronavirus Vaccine Barrons.com
10:18AM	ADP Gains 2.37M Jobs, Pfizer's COVID Drug Passes Test Zacks
10:08AM	Economic Data Deluge Zacks
09:36AM	BioNTech's stock halted, Pfizer shares jump on promising COVID-19 vaccine data MarketWatch
09:28AM	BioNTech to Hold Webcast to Present Early Positive Data from Ongoing Phase 1/2 Study of mRNA-based Vaccine Candidate Against SARS-CoV-2 GlobeNewswire
09:25AM	COVID-19 vaccine candidates with early human-trial data Reuters
09:19AM	BioNTech and Pfizer's COVID-19 vaccine shows potential in human trial Reuters
09:01AM	Pfizer and BioNTech Announce Early Positive Data from an Ongoing Phase 1/2 Study of mRNA-based Vaccine Candidate Against SARS-CoV-2 GlobeNewswire
08:59AM	Pfizer and BioNTech Announce Early Positive Data from an Ongoing Phase 1/2 study of mRNA-based Vaccine Candidate Against SARS-CoV-2 Business Wire
Jun-30-20 09:19PM	BioNTech and Pfizers Covid-19 vaccine trial yields positive results Financial Times
08:47AM	BioNTech (BNTX) Looks Good: Stock Adds 5.9% in Session Zacks
Jun-29-20 02:06PM	Race for a COVID-19 vaccine has drug makers scaling up manufacturing before one is developed MarketWatch +5.91%
06:08AM	Temasek-led investor group in $250 million vaccine bet on Germany's BioNTech Reuters
03:00AM	BioNTech to Raise USD 250 Million in Private Placement GlobeNewswire
Jun-25-20 11:43AM	Moderna Is the Latest Coronavirus Vaccine Partner for Catalent Barrons.com +9.10%
09:53AM	DJIA Today, Stocks Start Mixed After Jobless Data, As Covid Concerns Weigh; Boeing Downgraded, Nike Slips Ahead Of Q4 Report Investor's Business Daily
Jun-23-20 10:28AM	Translate Bio Stock Up 50% as Sanofi Commits $1.9 Billion to Its Covid-19 Vaccine Barrons.com -8.18%
Jun-18-20 06:18PM	CureVac to Work With Bank of America, Jefferies on IPO Bloomberg
Jun-17-20 10:14AM	CureVac's experimental coronavirus vaccine Reuters
Jun-16-20 01:18PM	Exclusive: CureVac becomes second company to test coronavirus vaccine in Germany - sources Reuters
12:06PM	Moderna Is Racing Toward a Covid-19 Vaccine, but the Field Is Getting Crowded Barrons.com
Jun-15-20 12:18PM	Germany Moves to Secure Stake in Virus Vaccine Developer Bloomberg
11:45AM	Germany Makes a Big Bet On a Covid-19 Vaccine Developer Once Coveted by Trump Barrons.com
11:37AM	Germany investing in coronavirus vaccine maker that it accused the Trump administration of trying to poach MarketWatch
Jun-13-20 06:22AM	Is BioNTech Stock a Buy? Motley Fool
Jun-12-20 12:31PM	Hedge Funds Are Nibbling On BioNTech SE (BNTX) Insider Monkey
Jun-11-20 08:23AM	Moderna Will Start Testing Its Covid-19 Vaccine on 30,000 People in July Barrons.com
03:00AM	Investment Plan for Europe: European Investment Bank to provide BioNTech with up to 100 million in debt financing for COVID-19 vaccine development and manufacturing GlobeNewswire
Jun-08-20 07:55AM	Drugmakers Target Coronavirus Vaccine in 2020: 4 Stocks in Focus Zacks
Jun-07-20 07:02AM	Is Moderna Really the Leader in the COVID-19 Vaccine Race? Motley Fool
Jun-05-20 11:59AM	Dont Judge Pfizer by Its Vaccine Efforts InvestorPlace
Jun-03-20 03:07PM	NYT: Trump identifies five drugmakers most likely to produce a viable COVID-19 vaccine MarketWatch
Jun-01-20 08:57AM	How BioNTech (BNTX) Stock Stands Out in a Strong Industry Zacks +5.59%
07:47AM	Drugmakers Focus on Coronavirus Vaccine by 2020: 4 Winners Zacks
May-31-20 07:32AM	Here's the Under-the-Radar Biotech That Could Beat Moderna at Its Own Game Motley Fool
May-29-20 09:59AM	Dow Jones Today, Stocks Open Mixed Ahead Of Trump China Remarks; Coronavirus Vaccine Stocks Rise, Zscaler Spikes On Earnings Investor's Business Daily +5.68%
May-28-20 11:34AM	ER doctor: 12-18 month coronavirus vaccine timeline 'is extremely optimistic' Yahoo Finance
May-26-20 10:52AM	The Zacks Analyst Blog Highlights: Moderna, Pfizer, BioNTech, Sanofi and GlaxoSmithKline Zacks
09:59AM	Novavax and Merck Fuel COVID-19 Vaccine Hopes Investopedia
May-22-20 07:29AM	Everything you need to know about the Oxford University vaccine and other efforts to beat coronavirus MarketWatch
May-21-20 05:51PM	BioNTechs COVID-19 Vaccine Program Has a Leg Up on Modernas, Says Analyst TipRanks
May-20-20 08:11AM	Better Buy: GlaxoSmithKline vs. Pfizer Motley Fool
May-19-20 06:50PM	U.S. Cases Rise 1.6%; N.Y. Allows Hospital Visits: Virus Update Bloomberg -15.92%
11:39AM	A Covid-19 Vaccine Could Be Worth Billions for Moderna and Its Rivals Barrons.com
May-18-20 11:20AM	Who Is Winning the COVID-19 Vaccine Race? Investopedia +21.58%
May-15-20 07:16PM	Inside the Science and Companies Racing to Develop a Covid-19 Vaccine Barrons.com
May-14-20 11:51AM	Coronavirus Vaccine Progress Accelerates Yahoo Finance
08:13AM	Earnings Update: BioNTech SE (NASDAQ:BNTX) Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts Simply Wall St.
May-13-20 03:29AM	H.C. Wainwright Sticks to Their Hold Rating for BioNTech SE Investing.com
01:00AM	BioNTech SE (BNTX) Q1 2020 Earnings Call Transcript Motley Fool
May-09-20 01:23PM	Pfizer Outsources Branded Drug Production to Focus on Experimental Coronavirus Vaccine Motley Fool
May-06-20 04:15PM	BioNTech Completes Acquisition of Neon Therapeutics GlobeNewswire
03:34PM	Trumps coronavirus task force shifts focus to vaccines and reopening Yahoo Finance Video
02:15PM	BioNTech (BNTX) Stock Could Stay Grounded For Now SmarterAnalyst
May-05-20 04:26PM	Pfizer and BioNTech announce the start of BNT162 vaccine trial Yahoo Finance Video +9.22%
04:13PM	Covid Report: Pfizer Begins Vaccine Study; Test Maker Surges On Demand Investor's Business Daily
02:58PM	Pfizer Begins Human Testing Of Coronavirus Vaccine In US, Michigan Among Manufacturing Centers Benzinga
02:01PM	Pfizer and BioNTech Begin U.S. Trials of SARS-CoV-2 Vaccine Candidate Motley Fool
01:06PM	Pfizer, BioNTech Shares Rise on U.S. Coronavirus Vaccine Trial Start SmarterAnalyst
11:10AM	Covering All Bases With Pfizer as It Aggressively Pursues a Covid-19 Vaccine TheStreet.com
10:11AM	Pfizer, BioNTech set to begin U.S. coronavirus vaccine trial Reuters
08:43AM	Pfizer and BioNTech Launch Human Trials of Covid-19 Vaccine TheStreet.com
06:45AM	Pfizer and BioNTech Dose First Participants in the U.S. as Part of Global COVID-19 mRNA Vaccine Development Program GlobeNewswire
06:00AM	BioNTech to Report First Quarter 2020 Financial Results and Operational Update on May 12, 2020 GlobeNewswire
May-03-20 03:31PM	Here's Why BioNTech Lost 18.7% in April Motley Fool
Apr-29-20 08:16PM	BioNTechs Potential COVID-19 Vaccine Is Already Priced In, Says JPMorgan SmarterAnalyst +7.46%
04:59PM	Pfizer and BioNTech Complete Dosing of First Group in Coronavirus Vaccine Trial Motley Fool
03:42AM	BioNTech and Pfizer announce completion of dosing for first cohort of Phase 1/2 trial of COVID-19 vaccine candidates in Germany GlobeNewswire
Apr-25-20 10:08AM	German biotech firm working on COVID-19 vaccines rejects takeover approaches Reuters
Apr-23-20 11:19AM	Pfizer/BioNTech to Begin Coronavirus Vaccine Study in Germany Zacks -6.54%
07:41AM	Germany approves first trial of COVID-19 vaccine candidate Reuters Videos
Apr-22-20 11:25AM	Pfizer Rises on Nod to Start First In-Human COVID-19 Vaccine Trial in Germany SmarterAnalyst +26.60%
07:56AM	U.S. Was Hit Earlier Than Thought; Singapore Surge: Virus Update Bloomberg
07:51AM	The Daily Biotech Pulse: Immunic To Develop COVID Treatment, Gilead Strikes IO Partnership Benzinga
06:57AM	Germany approves Covid-19 vaccine trial Financial Times
05:00AM	BioNTech and Pfizer announce regulatory approval from German authority Paul-Ehrlich-Institut to commence first clinical trial of COVID-19 vaccine candidates GlobeNewswire
Apr-20-20 08:53AM	BioNTech (BNTX) Soars: Stock Adds 5.2% in Session Zacks +6.27%
Apr-13-20 02:23AM	Pfizer Joins Virus Vaccine Hunt in Partnership With German Drugmaker SmarterAnalyst -8.15%
Apr-10-20 07:45PM	SHAREHOLDER ALERT: WeissLaw LLP Investigates Neon Therapeutics, Inc. PR Newswire
Apr-09-20 01:43PM	Pfizer, BioNTech, Arcturus Share Timelines For Human Testing As COVID-19 Vaccine Development Intensifies Benzinga
11:31AM	Covid Report: Pfizer Selects Lead Coronavirus Drug; Gilead Updates Tests Investor's Business Daily
08:38AM	Pfizer Aims to Test Early Coronavirus Treatment by Summer TheStreet.com

BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other diseases. The company is involved in developing FixVac product candidates, including BNT111, which is in Phase I clinical trial for advance melanoma; BNT112 for prostate cancer; BNT113 that is in Phase I clinical trial to treat HPV+ head and neck cancers; BNT114, which is in Phase I clinical trial for triple negative breast cancer; and BNT115 and BNT116 to treat other cancers, including ovarian cancer. It also develops individualized neo-antigen specific immunotherapies, such as RO7198457, which is in Phase II clinical trial for first-line melanoma, as well as in Phase I clinical trial to treat multiple solid tumors; mRNA intratumoral immunotherapy comprising SAR441000 that is in Phase I clinical trial for solid tumors; and BNT141 and BNT142 to treat multiple solid tumors. In addition, the company develops RiboCytokines, which include BNT151, BNT152, and BNT152 for multiple solid tumors; chimeric antigen receptor T cell immunotherapies, such as BNT211 to treat multiple solid tumors, and BNT212 for pancreatic and other cancers; next-generation checkpoint immunomodulators consisting of GEN1046 and GEN1042, which are in Phase I clinical trial to treat multiple solid tumors. Further, it develops MVT-5873, an IgG1 monoclonal antibody, which is in Phase I clinical trial for pancreatic cancer; BNT411, small molecule immunomodulator product candidate for solid tumors; and infectious disease immunotherapies and rare disease protein replacement therapies. The company has a collaboration with Pfizer Inc. to develop vaccines for the coronavirus using its mRNA-based drug development platform; and development and commercialization collaboration with Shanghai Fosun Pharmaceutical (Group) Co., Ltd. to advance a vaccine candidate BNT162 for the prevention of COVID-19 infections. The company was founded in 2008 and is headquartered in Mainz, Germany.

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience